Drug combination may become new standard treatment for advanced kidney cancer

A combination of two drugs — one of them an immunotherapy agent — could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial. Patients who received the immunotherapy drug avelumab plus axitinib, a targeted agent, had a… Read More »

Microrobots Take Minutes to Detect C. diff in Stool Samples

February 15th, 2019 Editors Diagnostics, GI, Materials, Medicine, Nanomedicine Detecting bacterial infestations within the GI system, particularly using low cost methods, takes so much time that treatment is often administered too late. Clostridium difficile (C. diff) is a particular nasty nuisance that kills many frail patients, and even with a hospital lab it can take up to… Read More »